Tromboprophylaxis

2010 NICE was a significant year for the prevention of Hospital Acquired Thrombosis (HAT) in the United Kingdom. NICE and SIGN published clinical guidance aimed at reducing the risk of hospital acquired thrombosis and the 1000 lives campaign was launched in Wales. Seven quality standards for VTE prevention were identified by the NICE Quality Board, reducing VTE became one of two national CQUIN goals, NHSLA criteria for VTE prevention were identified and it was highlighted as a top quality priority within QIPP. It is also a key patient safety issue and our courses are designed to promote clinical effectiveness and patient safety in this field. 

We offer courses designed either for those  working strategically to implement policies and procedures aimed and preventing venous thrombo-embolism or those working at ward level who are directly responsible for the delivery of effective thromboprophylaxis.


Examples of classroom based courses we have designed and delivered for our clients

Course 1

Title

VTE Prevention – developing effective strategies

Target Audience   

Health Care Professionals in senior positions working strategically to prevent VTE including members of the thrombosis committee, matrons, senior pharmacists, risk managers,

Aim                    

To explore key factors influencing the development and delivery of  effective strategies within the hospital setting for the prevention of VTE   

Key Content

  1. •Causes of VTE and associated consequences and conditions 

  2. •Strategies for chemical and mechanical thromboprophylaxis 

  3. •Patient education 

  4. •Risk assessment and management 

  5. •Clinical Audit 

  6. •Roles and Responsibilities 

  7. •Action Planning 

  8. •Leading change 

Course 2

Title

Thromboprophylaxis in Clinical Practice

Target Audience   

Health Care Professionals working directly with patients in the delivery of thromboprophylaxis

Aim                    

To explore key factors influencing the implementation of chemical and mechanical thromboprophylaxis and the maintenance of patient safety.   

Key Content

  1. •Causes of VTE and associated consequences and conditions 

  2. •Strategies for chemical and mechanical thromboprophylaxis 

  3. •The national agenda for VTE prevention – making it work locally – promoting patient safety through clinical and organisational risk assessment and management, patient education ,monitoring the quality of care - the role of audit and NICE Quality Standards

  4. •VTE prevention Action Point –developing an action plan for delegate’s clinical setting